Oncolys BioPharma Inc. (4588.T) JPX

923.00

-31(-3.25%)

Updated at December 05 03:30PM

Currency In JPY

Valuation

Market Cap11.31B
Enterprise Value9.47B
P/E Ratio-10.57
PEG Ratio6.59
Price/Sales Ratio830.39
Price/Book Ratio16.47
Enterprise/Revenue794.63
Enterprise/EBITDA-10.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-78.58
Operating Margin-75.5

Management Effectiveness

Return On Assets-1.16
Return On Equity-1.11

Income Statement

Revenue31.38M
Revenue/Share1.15
Gross Profit31.38M
EBITDA-1.68B
Net Income-1.68B
Diluted EPS-77.17

Balance Sheet

Total Cash1.39B
Total Cash/Share55.85
Total Debt377.04M
Total Debt/Equity0.25
Current Ratio6.78
Book Value Per Share57.91

Price History

52-Week Change50.71
52-Week High1,197
52-Week Low458
Moving Average 50 Days822.36
Moving Average 200 Days670.18

Statistics

Average Volume1.47M
Shares Outstanding24.85M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A